CBD (cannabidiol) is a naturally occurring compound found in the hemp plant. It is non-psychoactive, meaning it does not produce the “high” typically associated with cannabis.

CBD products derived from hemp containing less than 0.3% THC (tetrahydrocannabinol) are legal under federal law in the United States. However, laws regarding CBD products vary from state to state and from country to country.

CBD has been touted as potentially beneficial for a variety of health issues, including pain, inflammation, anxiety, and sleep disorders. However, more research is needed to fully understand its effects on the body.

CBD can be taken in a variety of forms, including oils, capsules, topicals, and edibles. The method of administration will depend on the individual’s preferences and the desired effect.

While CBD is generally considered safe, some people may experience side effects such as drowsiness, dry mouth, and changes in appetite or mood. It is important to talk to a healthcare provider before starting a CBD regimen, especially if you are taking other medications.

Absolutely. In addition to supplying a variety of cannabinoid-rich bulk ingredients, we also offer full-service white labeling in a wide range of categories.

At UML Biopharma, we produce a vast array of cannabinoid-rich raw materials. To fit the needs of your business, we offer raw materials in varying stages of potency and distillation, so whether you’d prefer to save by purchasing wholesale quantities of CBG or CBD biomass or you want to impress your customers with the unique qualities of THC-free ultra broad-spectrum distillate, UML has a solution for your brand. Some of our bulk ingredients are proprietary, which means that you can only get them from UML Biopharma.

We are the only manufacturer in China that produces the entire industrial chain of cannabinoids. Our production base is currently at the leading level in the industry in terms of planting, extraction, processing, and product quality. Moreover, our company is the only one in China that can produce pharmaceutical-grade products with a purity of up to 99.9%.

Our company has a professional and high-quality planting management team. Our planting technology has been 2-3 years ahead of competitors. In 2018, our company planted 3,500 acres of industrial hemp, harvested 200 tons of dried flowers and leaves, with an average CBD content of 0.5%. In 2019, we planted 8,000 acres of industrial hemp and harvested 900 tons of dried flowers and leaves, with an average CBD content of 3.5%. In 2020, we planted 6,000 acres of industrial hemp, harvested 1,000 tons of dried flowers and leaves, and the average CBD content was 5.0%. Our planting level and technology have been improved year by year, and we have been committed to breeding high CBD varieties for many years. At present, the new variety “Zhongsheng No. 1” independently bred by our company,

Our production base has a high-end professional R&D technology team, which focuses on industrial hemp planting, extraction, R&D, and product development. We constantly plan and develop exclusive products that meet the needs of the industrial hemp industry. Our industrial hemp variety content is already 3% ahead of our competitors (other companies were at 0.5% in 2019 and expected to reach about 5% in 2025, but our company had already expected to reach 3% in 2020). In terms of extraction technology, our company already has four patented invention technologies. All of our non-standard equipment in our production line is our company’s patented design. Its characteristics are short process path, high efficiency, high yield, and low operating cost. Our company is operating at full capacity.

Our current CBD product series have adapted to the needs of various international markets, and our product quality ranks first in the country. Our professional technical development team and production management team can provide customers with customized product development services. Our main products are CBD crystals (food grade 99%, pharmaceutical grade 99%), CBD oil, full-spectrum oil (THC 0.39%), broad-spectrum oil (THC-0), CBDV, CBN, CBC, CBG, and other minor cannabinoids. In 2020, our company has developed a water-soluble CBD with internationally leading quality (with a CBD content of 2% in water and no additives). Our CBD products have reached international standards, and our products are mainly sold in markets such as Japan, South Korea, North America, and Europe, gradually entering into various products such as food, cosmetics, health products, and beverages in those countries.

CBD (cannabidiol) is a naturally occurring compound found in the hemp plant. It is non-psychoactive, meaning it does not produce the “high” typically associated with cannabis.

CBD products derived from hemp containing less than 0.3% THC (tetrahydrocannabinol) are legal under federal law in the United States. However, laws regarding CBD products vary from state to state and from country to country.

CBD has been touted as potentially beneficial for a variety of health issues, including pain, inflammation, anxiety, and sleep disorders. However, more research is needed to fully understand its effects on the body.

CBD can be taken in a variety of forms, including oils, capsules, topicals, and edibles. The method of administration will depend on the individual’s preferences and the desired effect.

While CBD is generally considered safe, some people may experience side effects such as drowsiness, dry mouth, and changes in appetite or mood. It is important to talk to a healthcare provider before starting a CBD regimen, especially if you are taking other medications.

Absolutely. In addition to supplying a variety of cannabinoid-rich bulk ingredients, we also offer full-service white labeling in a wide range of categories.

At UML Biopharma, we produce a vast array of cannabinoid-rich raw materials. To fit the needs of your business, we offer raw materials in varying stages of potency and distillation, so whether you’d prefer to save by purchasing wholesale quantities of CBG or CBD biomass or you want to impress your customers with the unique qualities of THC-free ultra broad-spectrum distillate, UML has a solution for your brand. Some of our bulk ingredients are proprietary, which means that you can only get them from UML Biopharma.

We are the only manufacturer in China that produces the entire industrial chain of cannabinoids. Our production base is currently at the leading level in the industry in terms of planting, extraction, processing, and product quality. Moreover, our company is the only one in China that can produce pharmaceutical-grade products with a purity of up to 99.9%.

Our company has a professional and high-quality planting management team. Our planting technology has been 2-3 years ahead of competitors. In 2018, our company planted 3,500 acres of industrial hemp, harvested 200 tons of dried flowers and leaves, with an average CBD content of 0.5%. In 2019, we planted 8,000 acres of industrial hemp and harvested 900 tons of dried flowers and leaves, with an average CBD content of 3.5%. In 2020, we planted 6,000 acres of industrial hemp, harvested 1,000 tons of dried flowers and leaves, and the average CBD content was 5.0%. Our planting level and technology have been improved year by year, and we have been committed to breeding high CBD varieties for many years. At present, the new variety “Zhongsheng No. 1” independently bred by our company,

Our production base has a high-end professional R&D technology team, which focuses on industrial hemp planting, extraction, R&D, and product development. We constantly plan and develop exclusive products that meet the needs of the industrial hemp industry. Our industrial hemp variety content is already 3% ahead of our competitors (other companies were at 0.5% in 2019 and expected to reach about 5% in 2025, but our company had already expected to reach 3% in 2020). In terms of extraction technology, our company already has four patented invention technologies. All of our non-standard equipment in our production line is our company’s patented design. Its characteristics are short process path, high efficiency, high yield, and low operating cost. Our company is operating at full capacity.

Our current CBD product series have adapted to the needs of various international markets, and our product quality ranks first in the country. Our professional technical development team and production management team can provide customers with customized product development services. Our main products are CBD crystals (food grade 99%, pharmaceutical grade 99%), CBD oil, full-spectrum oil (THC 0.39%), broad-spectrum oil (THC-0), CBDV, CBN, CBC, CBG, and other minor cannabinoids. In 2020, our company has developed a water-soluble CBD with internationally leading quality (with a CBD content of 2% in water and no additives). Our CBD products have reached international standards, and our products are mainly sold in markets such as Japan, South Korea, North America, and Europe, gradually entering into various products such as food, cosmetics, health products, and beverages in those countries.